USFDA concludes inspection at Solara's Visakhapatnam facility with Zero 483 inspectional observations
Solara Active Pharma Sciences Ltd today announced that its new state-of-the-art multipurpose API manufacturing facility at Visakhapatnam, Andhra Pradesh completed successfully the inspection carried out by the US FDA.
Source: equitybulls.com